Recommended iodine dose for multiphasic contrast-enhanced mutidetector-row computed tomography imaging of liver for assessing hypervascular hepatocellular carcinoma: multicenter prospective study in 77 general hospitals in Japan.

[1]  R. Leggett,et al.  A proposed blood circulation model for Reference Man. , 1995, Health physics.

[2]  J. Heiken,et al.  Dynamic incremental CT: effect of volume and concentration of contrast material and patient weight on hepatic enhancement. , 1995, Radiology.

[3]  K. Bae,et al.  Intravenous contrast medium administration and scan timing at CT: considerations and approaches. , 2010, Radiology.

[4]  K Hanafusa,et al.  Small hepatocellular carcinomas: two-phase dynamic incremental CT in detection and evaluation. , 1993, Radiology.

[5]  M Takahashi,et al.  Multiple-phase helical CT of the liver for detecting small hepatomas in patients with liver cirrhosis: contrast-injection protocol and optimal timing. , 1996, AJR. American journal of roentgenology.

[6]  J A Brink,et al.  Aortic and hepatic contrast medium enhancement at CT. Part I. Prediction with a computer model. , 1998, Radiology.

[7]  Myeong-Jin Kim,et al.  Nodular hepatocellular carcinomas: detection with arterial-, portal-, and delayed-phase images at spiral CT. , 1997, Radiology.

[8]  K. Awai,et al.  Effect of contrast material injection duration and rate on aortic peak time and peak enhancement at dynamic CT involving injection protocol with dose tailored to patient weight. , 2004, Radiology.

[9]  Kazuo Awai,et al.  Effect of contrast injection protocol with dose tailored to patient weight and fixed injection duration on aortic and hepatic enhancement at multidetector-row helical CT , 2003, European Radiology.

[10]  B L Holbert,et al.  Hepatocellular carcinoma: evaluation with biphasic, contrast-enhanced, helical CT. , 1996, Radiology.

[11]  M Takahashi,et al.  Abdominal helical CT: evaluation of optimal doses of intravenous contrast material--a prospective randomized study. , 2000, Radiology.

[12]  近藤 浩史.  Abdominal multidetector CT in patients with varying body fat percentages : estimation of optimal contrast material dose , 2009 .

[13]  R B Jeffrey,et al.  Dual-phase helical CT of the liver: value of arterial phase scans in the detection of small (< or = 1.5 cm) malignant hepatic neoplasms. , 1995, AJR. American journal of roentgenology.

[14]  Gerald Antoch,et al.  Dual-energy-CT of hypervascular liver lesions in patients with HCC: investigation of image quality and sensitivity , 2011, European Radiology.

[15]  Ehsan Samei,et al.  Hypervascular liver tumors: low tube voltage, high tube current multidetector CT during late hepatic arterial phase for detection--initial clinical experience. , 2009, Radiology.

[16]  Sukru Mehmet Erturk,et al.  Effect of duration of contrast material injection on peak enhancement times and values of the aorta, main portal vein, and liver at dynamic MDCT with the dose of contrast medium tailored to patient weight. , 2008, Clinical radiology.

[17]  Sukru Mehmet Erturk,et al.  Multiphasic contrast-enhanced multidetector-row CT of liver: contrast-enhancement theory and practical scan protocol with a combination of fixed injection duration and patients' body-weight-tailored dose of contrast material. , 2006, European journal of radiology.

[18]  Takeshi Nakaura,et al.  Optimal contrast dose for depiction of hypervascular hepatocellular carcinoma at dynamic CT using 64-MDCT. , 2008, AJR. American journal of roentgenology.

[19]  D. DeLong,et al.  Determining contrast medium dose and rate on basis of lean body weight: does this strategy improve patient-to-patient uniformity of hepatic enhancement during multi-detector row CT? , 2007, Radiology.

[20]  E. Fishman,et al.  Quantitative and qualitative evaluation of volume of low osmolality contrast medium needed for routine helical abdominal CT. , 2001, AJR. American journal of roentgenology.